Literature DB >> 12905137

Asymptomatic infection with Borrelia burgdorferi.

Allen C Steere1, Vijay K Sikand, Robert T Schoen, John Nowakowski.   

Abstract

The natural history of asymptomatic seroconversion to Borrelia burgdorferi has been unclear. We report here, on the basis of a post hoc assessment, the frequency and outcome of asymptomatic seroconversion to B. burgdorferi in participants of a large Lyme disease vaccine trial. We show that infection with B. burgdorferi may be asymptomatic but that asymptomatic infection is unusual in the United States.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12905137     DOI: 10.1086/376914

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.

Authors:  Richard B Porwancher; C Greg Hagerty; Jianqing Fan; Lisa Landsberg; Barbara J B Johnson; Mark Kopnitsky; Allen C Steere; Karen Kulas; Susan J Wong
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

Review 3.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

4.  Value of Patient Population Selection and Lyme Borreliosis Tests.

Authors:  Alexis Lacout; Pierre Yves Marcy; Marie Mas; Christian Perronne; Michel Franck
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

Review 5.  The Lyme vaccine: a cautionary tale.

Authors:  L E Nigrovic; K M Thompson
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

Review 6.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

Review 7.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

8.  Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes.

Authors:  J Sjöwall; A Carlsson; O Vaarala; S Bergström; J Ernerudh; P Forsberg; C Ekerfelt
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

9.  A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.

Authors:  Nina Wressnigg; P Noel Barrett; Eva-Maria Pöllabauer; Maria O'Rourke; Daniel Portsmouth; Michael G Schwendinger; Brian A Crowe; Ian Livey; Thomas Dvorak; Bernhard Schmitt; Markus Zeitlinger; Herwig Kollaritsch; Meral Esen; Peter G Kremsner; Tomas Jelinek; Roland Aschoff; Roland Weisser; Ingomar F K Naudts; Gerald Aichinger
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

10.  Prospective study of serologic tests for lyme disease.

Authors:  Allen C Steere; Gail McHugh; Nitin Damle; Vijay K Sikand
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.